AAAS Student E-poster Competition Winners. The AAAS Student E-poster competition recognizes the individual efforts of students who are actively working toward an undergraduat ...

MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced three poster presentations at the 2025 American ...

PODO Therapeutics, a precision medicine-focused biotechnology company, today announced that it will present its latest research findings at the upcoming American Association for Cancer Research (AACR) ...

Plus Therapeutics (PSTV) announces the online availability of new data on its lead compound REYOBIQ in an abstract for both an oral ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Academy of Neurology (AAN) ...

In addition to keynote presentations and panel discussions ... showcasing their latest findings and developments in the field of cannabinoid-based medicine. This poster session will serve as a ...

including three oral presentations, one e-poster presentation, and eight poster presentations, highlighting the breadth of its research in respiratory and emerging infectious diseases.

In contrast to an oral presentation, a “poster” is a visual representation of the research project that must convey the essence of your message. In effect, it “talks” for the researcher. The poster ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...